Add to My Pictures
As a child, Justin was diagnosed with von Hippel-Lindau syndrome, a rare inherited disorder that increases the risk of developing noncancerous and cancerous tumors in multiple organs. Joining an NCI phase 2 trial of belzutifan (Welireg) as an adult changed Justin’s life.
This image is part of the NCI Annual Plan and Budget Proposal FY 2024 collection.
See also www.cancer.gov/research/annual-plan.
|Type:||Color, Photo (JPEG format)|
|Source:||Nation Cancer Institute (NCI)|
|Creator:||Nation Cancer Institute (NCI)|
|Date Created:||September 6, 2022|
|Date Added:||September 9, 2022|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|